Speakers

VP & General Manager, Rare Disease UK & Ireland, Alexion, AstraZeneca

Principal Scientist, Quotient Therapeutics

Programme Director: Commercial, Managed Access and Medicines Policy, NICE

Managing Director, CGT Incubator, Bayer

Director, AI for Science, GSK

Clinical Psychologist, Royal Free London NHS Foundation Trust

Professor e-One Health and Head of Statistical Multi-Omics, University of Surrey

SVP, Head of Research and Translational Science, Resolution Therapeutics

Chief Technology Officer, Rinri Therapeutics

Professor of Immunology, University of Oxford